SelectBIO Microfluidics, Circulating Biomarkers & Exosomes Asia 2020 will be held in Seoul Korea, September 14-15, 2020.

This conference brings together a focus on technology development as well as applications for biomarker analysis in cancer, cardiovascular disease and other disease classes.

The conference focuses heavily on the various classes of circulating biomarkers and emphasizes the many technology platforms currently being utilized to interrogate Circulating Cell-Free DNA (cfDNA), Circulating Tumor Cells (CTCs) and Extracellular Vesicles (EVs)/Exosomes.

Importantly, this conference brings together technologies in Microfluidics and Lab-on-a-Chip which together are impacting the study of circulating biomarkers such as CTCs, cfDNA and Exosomes/EVs.

The potential of EVs/Exosomes for Therapeutics Development and Drug Delivery are Presented as well as the Potential of EVs derived from Stem Cells for Regenerative Medicine.

This conference also features a showcase of companies involved in the study of cfDNA, CTCs and Exosomes and technologies in this space.

Korea is an excellent venue for this Asia/Pacific conference with a very strong scientific and technology focus and extensive research in this space plus the excellent conference location in Seoul is accessible from around the world to maximize networking and partnering activities at this conference.